对I型校正药物潜在CFTR结合部位的计算探索
Anna Lester1, Madeline Sandman1, Caitlin Herring1
1Berry College Department of Chemistry and Biochemistry, Mount Berry, Georgia 30149, United States.
Biochemistry
|July 12, 2023
概括
囊性纤维化 (CF) 药物校正剂与正常和F508del突变CFTR蛋白质的结合方式不同. F508del突变揭示了NBD1中的一个新的结合部位,显示出对CFTR校正器的更高亲和力.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 结构生物学 结构生物学
背景情况:
- 囊性纤维化 (CF) 是一种由CFTR蛋白突变引起的遗传疾病.
- 通过修复突变CFTR,CFTR校正药物可以提高预期寿命.
- VX-809 (lumacaftor) 是一个FDA批准的CFTR校正剂,向常见的F508del突变.
研究的目的:
- 调查CFTR校正药物在野生型和F508del突变CFTR上的潜在结合部位.
- 了解像VX-809这样的校正药物如何在分子水平上与CFTR相互作用.
- 确定设计更有效的CFTR校正疗法的新目标.
主要方法:
- 进行了集体对接模拟.
- 使用了一个结构相似的校正药物库,包括VX-809,VX-661和ABBV-2222.
- 对野生型CFTR和F508del-CFTR进行了模拟.
主要成果:
- 野生类型的CFTR仅在膜跨域1 (MSD1) 的一个位点上显示了对校正剂的有利结合.
- F508del-CFTR还在MSD1位点结合了校正剂,但这种突变还在核酸结合域1 (NBD1) 中额外打开了一个结合位点.
- 在F508del-CFTR中的NBD1位点对测试的校正药物表现出最强的结合亲和力.
结论:
- CFTR中的F508del突变改变了蛋白质结构,在NBD1.1中为校正药物创造了一个高亲和度的结合部位.
- 了解这些差异性结合机制对于开发下一代CFTR调节器至关重要.
- 这项研究为设计改进的CFTR校正药物提供了洞察力,提高了疗效.
更多相关视频
07:04Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
19.3K
06:59A Fluorescence-Based Assay of Membrane Potential for High-Throughput Functional Study of Two Endogenous Ion Channels in Two Epithelial Cell Lines
Published on: June 22, 2022
2.2K
相关概念视频
01:49Conserved Binding Sites
4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
00:49Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
01:19Allosteric Proteins-ATCase
5.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K